Novel endogenous angiogenesis inhibitors and their therapeutic potential
about
Macrophage migration inhibitory factor: a potential driver and biomarker for head and neck squamous cell carcinomaWhat is known about melatonin, chemotherapy and altered gene expression in breast cancerLooking for the Word "Angiogenesis" in the History of Health Sciences: From Ancient Times to the First Decades of the Twentieth Century.DW10075, a novel selective and small-molecule inhibitor of VEGFR, exhibits antitumor activities both in vitro and in vivo.Rho-GTPase activating-protein 18: a biomarker associated with good prognosis in invasive breast cancer.Use of animal models for the imaging and quantification of angiogenesis.Pathophysiology of the disturbed angiogenesis in hemophilia.The Challenges of Recombinant Endostatin in Clinical Application: Focus on the Different Expression Systems and Molecular Bioengineering.ERK activation in endothelial cells is a novel marker during neovasculogenesis.In vitro significance of SOCS-3 and SOCS-4 and potential mechanistic links to wound healing.Precision cancer medicine: where to target?ARHGAP18 is a novel gene under positive natural selection that influences HbF levels in β-thalassaemia.Refuting the hypothesis that semaphorin-3f/neuropilin-2 exclude blood vessels from the cap mesenchyme in the developing kidney.An andrographolide derivative AGP-26b exhibiting anti-angiogenic activity in HUVECs and zebrafish via blocking the VEGFA/VEGFR2 signaling pathway.Recombinant TSR1 of ADAMTS5 Suppresses Melanoma Growth in Mice via an Anti-angiogenic Mechanism.Angiogenesis: Managing the Culprits behind Tumorigenesis and MetastasisAssociation of specific gene mutations derived from machine learning with survival in lung adenocarcinoma
P2860
Q28068581-D4CF583E-6F37-47AE-B87F-290C074EC120Q33597963-CCD91E34-9C03-4578-92A4-ED428976A320Q36095216-0FEF887E-18CC-4B32-85F2-0849756F792DQ36644256-2F24844F-CDB1-4C5A-A51E-0D7488FA622FQ38614205-5E1B477F-AEDA-4C1D-923A-B702D66746B5Q38649616-869903E1-B1C3-46BC-8A40-0B5C36CCC2D8Q38821575-D3F6D517-40E9-4FB8-B8BC-A485D84F3C06Q39308829-1E89DB02-4C87-4341-8A0B-A7A466FA4122Q39328290-5A43206A-D161-4BCA-9520-FBB193D96A10Q41158794-F9C67AE1-999A-465A-89A8-4D9E8284403FQ43170563-1AE90C76-2FD7-497E-8D39-1D1414254E8AQ47853382-59789E57-A3C4-4B7E-A053-53243F0896CFQ47956039-7DF1024E-E5FB-4276-8D63-665F71236BA9Q48341194-C6C320E0-D8A7-4707-AF6D-A138AE2BDAEBQ55504021-8DABEB9C-06E8-4418-982F-9EFBE3C28E09Q57825996-86FCC5A2-341F-434D-A453-F58AC2E07B60Q59136814-D0244238-7198-4E39-BC7D-EF277E6A4A2A
P2860
Novel endogenous angiogenesis inhibitors and their therapeutic potential
description
2015 nî lūn-bûn
@nan
2015 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Novel endogenous angiogenesis inhibitors and their therapeutic potential
@ast
Novel endogenous angiogenesis inhibitors and their therapeutic potential
@en
Novel endogenous angiogenesis inhibitors and their therapeutic potential
@nl
type
label
Novel endogenous angiogenesis inhibitors and their therapeutic potential
@ast
Novel endogenous angiogenesis inhibitors and their therapeutic potential
@en
Novel endogenous angiogenesis inhibitors and their therapeutic potential
@nl
prefLabel
Novel endogenous angiogenesis inhibitors and their therapeutic potential
@ast
Novel endogenous angiogenesis inhibitors and their therapeutic potential
@en
Novel endogenous angiogenesis inhibitors and their therapeutic potential
@nl
P2860
P356
P1476
Novel endogenous angiogenesis inhibitors and their therapeutic potential
@en
P2093
Nithya Rao
Yu Fei Lee
P2860
P2888
P304
P356
10.1038/APS.2015.73
P407
P50
P5008
P577
2015-10-01T00:00:00Z
P5875
P6179
1001981815